ArticleObstetrics and gynecology2016
Fertility Treatments in the United States: Improving Access and Outcomes.
Article in Obstetrics and gynecology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 40 citations in OpenAlex.
- Supporting Women Undergoing IVF Treatment With Timely Patient Information Through an App: Randomized Controlled Trial.JMIR mHealth and uHealth · 2021Trial
- Epidemiological characteristics of infertility, 1990-2021, and 15-year forecasts: an analysis based on the global burden of disease study 2021.Reproductive health · 2025Article
- U.S. young adults' family-building intentions in the event of infertility and knowledge of associated costs.Frontiers in global women's health · 2025Article
- Highly Purified Human Menopausal Gonadotropin (HP-hMG) Versus Recombinant Follicle-Stimulating Hormone (rFSH) for Controlled Ovarian Stimulation in US Predicted High-Responder Patients: A Cost-Comparison Analysis.PharmacoEconomics - open · 2023Article
- Access to Fertility Care in Geographically Underserved Populations, a Second Look.Reproductive sciences (Thousand Oaks, Calif.) · 2022Review
- The Future of Assisted Reproductive Technology Live Births in the United States.Population research and policy review · 2022Article
- Worldwide trend analysis of primary and secondary infertility rates over past decades: A cross-sectional study.International journal of reproductive biomedicine · 2022Article
- Self-reported barriers to accessing infertility care: patient perspectives from urban gynecology clinics.Journal of assisted reproduction and genetics · 2020Article
- Health systems recovery from COVID-19: a window of opportunity for (in)fertility care.Sexual and reproductive health matters · 2020Article
- Infertility policy analysis: a comparative study of selected lower middle- middle- and high-income countries.Globalization and health · 2020Article
- Assisted reproductive technology use in the United States: a population assessment.Fertility and sterility · 2019Article
- Assisted Reproductive Technology Surveillance - United States, 2016.Morbidity and mortality weekly report. Surveillance summaries (Washington, D.C. : 2002) · 2019Article
- Child Health: Is It Really Assisted Reproductive Technology that We Need to Be Concerned About?Seminars in reproductive medicine · 2018Review
- Assisted Reproductive Technology Surveillance - United States, 2015.Morbidity and mortality weekly report. Surveillance summaries (Washington, D.C. : 2002) · 2018Article
- Assisted hatching and live births in first-cycle frozen embryo transfers.Fertility and sterility · 2017Article
- Disparities in Assisted Reproductive Technology Utilization by Race and Ethnicity, United States, 2014: A Commentary.Journal of women's health (2002) · 2017Article
- Assisted Reproductive Technology Surveillance - United States, 2014.Morbidity and mortality weekly report. Surveillance summaries (Washington, D.C. : 2002) · 2017Article
- Low semen quality and adverse histological changes in testes of adult male mice treated with bee venom (Open veterinary journalArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
Abstract
The recently released National Public Health Action Plan for the Detection, Prevention, and Management of Infertility calls for better access to high-quality infertility services and improved safety of fertility treatments. Both assisted reproductive technology (ART) and non-ART fertility treatments have allowed millions of patients worldwide to overcome infertility-a disease of the reproductive system and important public health issue. However, there are substantial disparities in access to effective treatments in the United States, largely attributable to high out-of-pocket costs, especially for ART. Moreover, the outcomes of fertility treatments are often complicated by the large proportion of multiple births with substantial health risks for both neonates and mothers. Prevention of multiple births is difficult during non-ART fertility treatments but can be effective with single-embryo transfer during ART. Several U.S. states have enacted legislative mandates that require private insurers to cover some portion of the costs associated with fertility treatments and thus reduce the financial pressure to transfer multiple embryos during ART. Although studies have shown that insurance coverage reduces per-cycle multiple births to a certain degree, states with insurance mandates have more ART-related multiple births attributable to substantially larger number of ART-conceived neonates. Experience from other countries shows that access to ART can be improved without concomitant increases in multiple births by providing reimbursement for ART in combination with restrictions on the number of embryos transferred per cycle. Such approaches may or may not be successful in the United States with its unique and complex health care system.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.